Application of Damage Control Resuscitation Strategies to Patients with Severe Traumatic Hemorrhage: Review of Plasma to Packed Red Blood Cell Ratios at a Single Institution
Abstract:When treating trauma patients with severe hemorrhage, massive transfusions are often needed. Damage control resuscitation strategies can be used for such patients, but an adequate fresh frozen plasma: packed red blood cell (FFP:PRBC) administration ratio must be established. We retrospectively reviewed the medical records of 100 trauma patients treated with massive transfusions from March 2010 to October 2012. We divided the patients into 2 groups according to the FFP:PRBC ratio: a high-ratio (≥0.5) and a low-… Show more
“…Sensitivity studies using leave one out analysis of 24-hour and 30-day/in-hospital mortality at different ratios were done. (Supplementary figure 3) Morbidity ARDS data was available from 8 studies 2,14,28,29,35,40,45,46 and ALI data was reported in 2 studies 14,28 . There was no difference in the incidence of ARDS with respect to FFP: RBC ratio (OR: 0.68, CI 0.40-1.16, P=0.16).…”
“…Sensitivity studies using leave one out analysis of 24-hour and 30-day/in-hospital mortality at different ratios were done. (Supplementary figure 3) Morbidity ARDS data was available from 8 studies 2,14,28,29,35,40,45,46 and ALI data was reported in 2 studies 14,28 . There was no difference in the incidence of ARDS with respect to FFP: RBC ratio (OR: 0.68, CI 0.40-1.16, P=0.16).…”
“…Whilst such protocols have been found to reduce morbidity and mortality, [ 35 ] the requirement for such large amounts of clotting products and the exact composition of this transfusion regime does remain controversial [ 36 ]. An observational study recently demonstrated the early survival benefits of delivering clotting product to red cell ratios above 0.5:1 in patients with severe haemorrhage [ 37 ]. Conversely, recent military evidence suggests that ratios of a low as 0.35:1 may be preferable [ 38 ].…”
BackgroundDamage control resuscitation describes an approach to the early care of very seriously injured patients. The aim is to keep the patient alive whilst avoiding interventions and situations that risk worsening their situation by driving the lethal triad of hypothermia, coagulopathy and acidosis or excessively stimulating the immune-inflammatory system. It is critical that the concepts and practicalities of this approach are understood by all those involved in the early management of trauma patients. This review aims to summarise this and discusses current knowledge on the subject.InterventionsDamage control resuscitation forms part of an overall approach to patient care rather than a specific intervention and has evolved from damage control surgery. It is characterised by early blood product administration, haemorrhage arrest and restoration of blood volume aiming to rapidly restore physiologic stability. The infusion of large volumes of crystalloid is no longer appropriate, instead the aim is to replace lost blood and avoid dilution and coagulopathy. In specific situations, permissive hypotension may also be of benefit, particularly in patients with severe haemorrhage from an arterial source. As rapid arrest of haemorrhage is so important, team-based protocols that deliver patients rapidly but safely, via CT scan where appropriate, to operating theatres or interventional radiology suites form a critical part of this process.ConclusionsGiven that interventions are so time dependent in the severely injured, it is likely that by further improving trauma systems and protocols, improvements in outcome can still be made. Further research work in this area will allow us to target these approaches more accurately to those patients who can benefit most.
“…Plasma contains all proteins involved in secondary hemostasis and the essential von Willebrand factor (vWF) for initiating primary hemostasis and stabilizing Factor (F) VIII in secondary hemostasis. Rapid replenishment of plasma loss is critical in the acute phase of trauma/hemorrhage under damage control resuscitation practice . Currently, fresh frozen plasma (FFP) and plasma frozen within 24 hours are the most commonly used plasma products.…”
BACKGROUND: Dried plasma is logistically superior for hemostasis management because it can be transported and stored under nonfrozen conditions and quickly reconstituted at the point of care, enabling prehospital administration. Velico Medical has developed a spray-drying system to be integrated into routine blood center work streams for spray drying single donor plasma units. This study compared the quality of the spray-dried plasma (on-demand plasma [ODP]) with fresh frozen plasma (FFP).
STUDY DESIGN AND METHODS: ODP units (n = 60)were manufactured from never frozen fresh plasma, which was pretreated with glycine-hydrochloric acid and stored at 1to 6 C. Paired aliquots were frozen and stored at −18 C or less. After 31 to 33 days, ODP samples were reconstituted with water for injection and comprehensively characterized in parallel with paired FFP. The quantities of plasma dried and rehydration fluid were predetermined, ensuring comparable total protein concentration in ODP and paired FFP.
RESULTS:ODP is comparable to FFP in global coagulation function as assessed by activated partial thromboplastin time and prothrombin time and in clot formation evaluated by thrombelastography. Compared to FFP, ODP had greater than 80% levels of functional coagulation factors and related proteins and chemistry analytes except for Factor XIII (74%). Pretreatment mitigated cleavage of high-molecular-weight von Willebrand factor multimers by spray drying and resulted in 60% vWF:ristocetin cofactor activity in ODP compared to FFP.
CONCLUSIONS: ODP demonstrates coagulationfunction comparable to that of FFP. The spray drying system can be implemented in blood centers and is capable of producing units of ODP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.